HealthLynked (HLYK) Current Deferred Revenue (2020 - 2026)

HealthLynked has disclosed Current Deferred Revenue across 7 years of filings, most recently posting $30598.0 for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 85.97% year-over-year to $30598.0; the TTM figure through Mar 2026 stood at $30598.0 (down 85.97% YoY), while the FY2025 annual figure was $25924.0, down 88.85% from the prior year.
• Current Deferred Revenue improved to $30598.0 in Q1 2026, from $25924.0 in the prior quarter.
• Over the last five years, Current Deferred Revenue for HLYK reached as high as $575843.0 in Q1 2023 and fell as low as $25924.0 in Q4 2025.
• The 5-year median for Current Deferred Revenue is $212793.0 (2024), against an average of $217968.9.
• Annual changes were most pronounced in 2023 — Current Deferred Revenue surged 1626.77% — and 2025, when it plunged 88.85%.
• A 5-year view of Current Deferred Revenue shows it stood at $574847.0 in 2022, then plunged by 52.72% to $271774.0 in 2023, then slipped by 14.43% to $232545.0 in 2024, then sank by 88.85% to $25924.0 in 2025, then climbed by 18.03% to $30598.0 in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $30598.0, $25924.0, and $47735.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.